Efficacy of Macrolide Immunomodulation in Severe Sepsis.

NCT00708799 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

100

Enrollment

FED

Sponsor class

Stopped Safety evaluation due to recent publications.

Conditions

Systemic Inflammatory Response Syndrome

Interventions

OTHER: Azithromycin on admission - not enrolled in the RCT

Sponsor

VA Office of Research and Development

Collaborators

[object Object]
[object Object]